Key result
Tirofiban infusion following acute coronary syndrome can induce acute diffuse alveolar hemorrhage, a rare complication often confused with other respiratory syndromes.
Tirofiban infusion can rarely induce diffuse alveolar hemorrhage, which must be differentiated from other respiratory syndromes to avoid delayed treatment.
Raises awareness of tirofiban-associated alveolar hemorrhage in ACS; leaves open incidence and risk factors for prospective study.
Alveolar hemorrhage is a dreaded complication which is seen rarely following the use of tirofiban, it is often confused with other respiratory syndromes resulting in inappropriate or delayed treatment. We present a case of acute alveolar hemorrhage following tirofiban infusion following acute coronary syndrome.
No takes yet. Share an insight, caveat, or question.
Kadeli et al. (2018) studied this question. Tirofiban infusion following acute coronary syndrome can induce acute diffuse alveolar hemorrhage, a rare complication often confused with other respiratory syndromes.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: